Market News AIOpen the app

CytoSorbents Corp shared its Q3 2026 results, showing higher revenue and breaking even on cash flow.

ResultsRead the original at SEC EDGAR
Good for CTSO

CytoSorbents raised sales 3%, lifted its gross margin to 75%, and generated $43,000 in operating cash before restructuring payments. Its $5.7 million cash balance and larger nine-month loss are concerns, but better quarterly results make this update favorable.

CTSO · CytoSorbents Corp

AI read · Good for CTSO

The AI's read

Lower costs and a wider product margin helped shrink operating losses. That points to better control of spending, even though sales grew only slightly. The company had $5.7 million in cash, and its nine-month reported loss rose to $12.0 million from $2.7 million. The company said currency results drove that increase. Better quarterly operations and positive operating cash flow outweigh those concerns.

Get alerts for CTSO

Follow CytoSorbents Corp (CTSO) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CTSO
Free on the App Store and Google Play, or on the web.